Dawn Halkuff Xeris Biopharma Holdings, Inc. (XERS) insider trading activity

XERS Quotes by TradingView

Dawn Halkuff is Director of Xeris Biopharma Holdings, Inc.. Currently has a direct ownership of 115,000 shares of XERS, which is worth approximately $890,100. The most recent transaction as insider was on Aug 12, 2025, when has been sold 42,500 shares (Common Stock) at a price of $7.28 per share, resulting in proceeds of $309,400. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 115K
26.98% 3M change
6.98% 12M change
Total Value Held $890,100

DAWN HALKUFF Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 12 2025
SELL
Open market or private sale
$309,400 $7.28 p/Share
42,500 Reduced 26.98%
115,000 Common Stock
Jun 04 2025
BUY
Grant, award, or other acquisition
-
50,000 Added 24.1%
157,500 Common Stock
Jun 05 2024
BUY
Grant, award, or other acquisition
-
50,000 Added 31.75%
107,500 Common Stock
Jun 07 2023
BUY
Grant, award, or other acquisition
-
42,500 Added 42.5%
57,500 Common Stock
Jun 08 2022
BUY
Grant, award, or other acquisition
-
15,000 Added 50.0%
15,000 Common Stock

Also insider at

XERS
XERIS PHARMACEUTICALS INC Healthcare
Director
DH

Dawn Halkuff

Director
Chicago, IL

Track Institutional and Insider Activities on XERS

Follow Xeris Biopharma Holdings, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells XERS shares.

Notify only if

Insider Trading

Get notified when an Xeris Biopharma Holdings, Inc. insider buys or sells XERS shares.

Notify only if

News

Receive news related to Xeris Biopharma Holdings, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on XERS